Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: William Strop who wrote (1055)	7/6/1999 10:12:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 1972

Just picked it up at the airport today, am only part way thru. wILL TRY TO POST RELEVENT STUFF. sCOTT

To: William Strop who wrote (1055)	7/7/1999 1:51:00 PM
From: Mike McFarland	Respond to of 1972

And for those that do not subscribe to the print copy of SciAm...I see that the gene vaccine article is online now... Genetic Vaccines Vaccines crafted from genetic material might one day prevent AIDS, malaria and other devastating infections that defy current immunization technologies. They may even help treat cancer by David B. Weiner and Ronald C. Kennedy sciam.com this schematic is nice to have handy sciam.com

To: William Strop who wrote (1055)	7/14/1999 11:30:00 AM
From: Scott H. Davis	Read Replies (2) \| Respond to of 1972

Don't see any news, no changes in the anticipated news from the Vical page, no current conferences biz.yahoo.com No analyst uprades/initiations announced. The BW artical was OK but VICL was just a sidenote in a few places, so I have no idea what's driving this rally, other than some rotation into small caps out of large cap growth due to the huge valuation disparity. Any ideas? Is the market getting over it's cluelesness? I don't know, but sure am appreciating the recent run. Scott